Skip to content

Insulet PODD EPS (Diluted)

EPS (Diluted) at other companies

Eli Lilly logo
Eli LillyLLY
$8.26+170%
Medtronic logo
MedtronicMDT
$0.97+18.3%
West Pharmaceutical Services logo
West Pharmaceutical ServicesWST
$1.92+56.1%
Abbott logo
AbbottABT
$0.61-19.7%
Viatris logo
ViatrisVTRS
$0.15+106%

Other financials

Income statement

See full
Revenue$761.7M+33.9%
Gross profit$529.0M+29.3%
Operating income$122.1M+37.5%
Net income$91.1M+157%

Balance sheet

See full
Cash & equivalents$480.4M-62.6%
Total debt$969.7M-45.5%
Total equity$1.3B-2.1%
Total assets$3.0B-15.1%

Cash flow

See full
Operating cash flow$113.8M+78.4%
CapEx$24.3M+97.6%
Free cash flow$89.5M+73.8%

Valuation

See full
Market cap$10.1B-19.9%
Enterprise value$10.59B-19.4%
P/E33.3×+2.0×
P/S3.5×-2.3×

Profitability

See full
Gross margin71%+0.6pp
Operating margin17.5%+2.0pp
Net margin10.4%-7.9pp
FCF margin14.3%+1.1pp

Returns & leverage

See full
Return on equity23%-14.9pp
Debt / equity0.7×-0.6×
Current ratio2.5×-2.0×

Where this comes from

Reported directly by Insulet in its filing.

Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.

The official record: Insulet’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Insulet's eps (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Insulet's EPS (diluted)?
Insulet (PODD) reported EPS (diluted) of $1.30 in Q1 2026.
How has Insulet's EPS (diluted) changed year-over-year?
Insulet's EPS (diluted) increased by 160.0% year-over-year, from $0.50 to $1.30.
What is the long-term trend for Insulet's EPS (diluted)?
Over 4 years (2021 to 2025), Insulet's EPS (diluted) has grown at a 97.4% compound annual growth rate (CAGR), from $0.23 to $3.49.
What does EPS (diluted) mean?
The profit per share assuming all potential dilutive securities are converted.
How do you interpret EPS (diluted)?
A smaller gap between basic and diluted EPS indicates a lower risk of share dilution for existing investors.
How does EPS (diluted) compare across companies?
Widely used by institutional investors to assess the true earnings potential of a company after accounting for equity-based compensation.